Takeda Destroyed Evidence In $9B Cancer Suit, Judge Says
By Juan Carlos Rodriguez (June 20, 2014, 8:13 PM EDT) -- A Louisiana federal judge said Friday that Takeda Pharmaceuticals Co. Ltd. intentionally destroyed evidence that would have helped the plaintiffs in a $9 billion bellwether lawsuit over claims the company hid the cancer risks of diabetes drug Actos to keep sales high.
The ruling from U.S. District Judge Rebecca Doherty follows plaintiffs Terrence and Susan Allen's April victory in the first federal jury decision in multidistrict litigation against Asia's largest drug company and its American partner, Eli Lilly & Co. The jury hit Takeda with $6 billion in punitive damages and Eli Lilly with $3 billion. The companies, which jointly marketed...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!